China Bans Daewoong's Cefmetazole Antibiotic Until Allowed To Inspect
This article was originally published in PharmAsia News
Executive Summary
China has issued a ban on imports of a set of the cefmetazole injectable antibiotic made by Daewoong Pharmaceutical in South Korea until its production facilities could be examined by the China FDA.